SCHEMBL7538776

SCHEMBL7538776

CCOc1cc(C=NOC)ccc1O

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.74
KMT2A Q03164 4/20 0.74
SRC P12931 1/20 0.63
ALDH1A1 P00352 1/20 0.62
L3MBTL1 Q9Y468 2/20 0.62
ALPI P09923 1/20 0.62
ALPG P10696 1/20 0.62
KDM4E B2RXH2 1/20 0.60
HPGD P15428 1/20 0.60
TOP2A P11388 1/20 0.58
ABL1 P00519 1/20 0.57
ABCB1 P08183 1/20 0.57
BCR P11274 1/20 0.57
PTGS1 P23219 1/20 0.55
PTGS2 P35354 1/20 0.55
GAA P10253 6/20 0.53
MAPT P10636 2/20 0.52
RAB9A P51151 1/20 0.52
POLB P06746 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7538773 1.00 MEN1 (0.74) MEN1KMT2ASRCALDH1A1L3MBTL1
SCHEMBL2570389 0.88 MEN1 (0.74) MEN1KMT2AALDH1A1L3MBTL1ALPI
SCHEMBL2570390 0.88 MEN1 (0.74) MEN1KMT2AALDH1A1L3MBTL1ALPI
SCHEMBL2608363 0.85 MEN1 (1.00) MEN1KMT2AALDH1A1L3MBTL1ALPI
SCHEMBL2571081 0.84 MEN1 (0.79) MEN1KMT2AALDH1A1L3MBTL1ALPI
SCHEMBL7716888 0.84 MEN1 (0.79) MEN1KMT2AALDH1A1L3MBTL1ALPI
SCHEMBL7330250 0.83 SRC (0.71) MEN1KMT2ASRCALDH1A1ALPI
SCHEMBL7330245 0.83 SRC (0.71) MEN1KMT2ASRCALDH1A1ALPI
SCHEMBL16199459 0.83 KMT2A (0.88) MEN1KMT2AALDH1A1L3MBTL1ALPI
Hydrochloric Acid SCHEMBL7331650 0.82 SRC (0.69) MEN1KMT2ASRCALDH1A1ALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0672746-B1 Oxime ethers and perfume and flavouring compositions containing them GIVAUDAN SA (CH) 2002-05-29 EP claimed
EP-0672746-A1 Oxime ethers and perfume and flavouring compositions containing them GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 1995-09-20 EP claimed
CN-113073006-A Improvements in or relating to organic compounds 奇华顿股份有限公司 2021-07-06 CN disclosed
EP-2917317-B1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2017-08-09 EP disclosed
US-20150299614-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN S.A. (CH) 2015-10-22 US disclosed
EP-2917317-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Givaudan SA (CH) 2015-09-16 EP disclosed
CN-104769089-A Improvements in or relating to organic compounds GIVAUDAN SA 2015-07-08 CN disclosed
WO-2014072519-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2014-05-15 WO disclosed
EP-0672746-A1 Oxime ethers and perfume and flavouring compositions containing them GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 1995-09-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299614-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS ALOX12, NR1H2, CYP19A1 MEN1 1407/4885KMT2A 1348/4885SRC 2477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.